Renin-angiotensin blockade reduces readmission for acute chest syndrome in sickle cell disease

Authors

Nneoma Wamkpah, Washington University School of Medicine in St. Louis
Anuj Shrestha, University of Missouri-Kansas City
Gary Salzman, University of Missouri-Kansas City
Stephen Simon, University of Missouri-Kansas City
Sahil Suman, University of Missouri-Kansas City
Alan Poisner, University of Missouri-Kansas City
Agostino Molteni, University of Missouri-Kansas City

Journal

Cureus

Publication Date

3-1-2022

Volume

14

Issue

3

First Page

e23567

Document Type

Open Access Publication

DOI

10.7759/cureus.23567

Rights and Permissions

Wamkpah N, Shrestha A, Salzman G, Simon S, Suman S, Poisner A, Molteni A. Renin-Angiotensin Blockade Reduces Readmission for Acute Chest Syndrome in Sickle Cell Disease. Cureus. 2022 Mar 28;14(3):e23567. doi.org/10.7759/cureus.23567.© Copyright 2022 Wamkpah et al. This is an open access article distributed under the terms of the Creative Commons Attribution License CC-BY 4.0., which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Recommended Citation

Wamkpah, Nneoma; Shrestha, Anuj; Salzman, Gary; Simon, Stephen; Suman, Sahil; Poisner, Alan; and Molteni, Agostino, "Renin-angiotensin blockade reduces readmission for acute chest syndrome in sickle cell disease." Cureus. 14, 3. e23567 (2022).
https://digitalcommons.wustl.edu/open_access_pubs/11899